Erratum: The costimulatory immunogen LPS induces the B-Cell clones that infiltrate transplanted human kidneys (Proceedings of the National Academy of Sciences of the United States of America (2012) 109:16 (6036-6041) DOI: 10.1073/pnas.1202214109);The costimulatory immunogen LPS induces the B-cell clones that infiltrate transplanted human kidneys

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 16, 2012, Pages 6036-6041

  Grover, Rajesh K ^a   Cheng, Julong ^a   Peng, Yingjie ^a   Jones, Teresa M ^a   Ruiz, Diana I ^a   Ulevitch, Richard J ^a   Glass, John I ^c   Dennis, Edward A ^b   Salomon, Daniel R ^a   Lerner, Richard A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c J CRAIG VENTER INSTITUTE   (United States)

Author keywords

Anti LPS antibody; Antibody library; Immunochemistry; Kidney rejection; Transplantation

Indexed keywords

ANTIBODY; B LYMPHOCYTE RECEPTOR; BACTERIUM LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE ANTIBODY; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; BACTERIAL INFECTION; CELL INFILTRATION; ESCHERICHIA COLI; HUMAN; HUMAN CELL; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE;

EID: 84859962773     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1615722113     Document Type: Erratum

References (46)

1. Meier-Kriesche HU, Schold JD, Kaplan B (2004) Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant 4:1289-1295. (Pubitemid 39013575)
2. Naesens M, et al. (2011) Progressive histological damage in renal allografts is associated with expression of innate and adaptive immunity genes. Kidney Int 80:1364-1376.
3. Cheng J, et al. (2011) Ectopic B-cell clusters that infiltrate transplanted human kidneys are clonal. Proc Natl Acad Sci USA 108:5560-5565.
4. Zarkhin V, Chalasani G, Sarwal MM (2010) The yin and yang of B cells in graft rejection and tolerance. Transplant Rev (Orlando) 24:67-78.
5. Li L, et al. (2009) Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and "antibodyome" measures. Proc Natl Acad Sci USA 106:4148-4153.
6. Nath DS, Basha HI, Mohanakumar T (2010) Antihuman leukocyte antigen antibody-induced autoimmunity: role in chronic rejection. Curr Opin Organ Transplant 15:16-20.
7. Zarkhin V, et al. (2008) Characterization of intra-graft B cells during renal allograft rejection. Kidney Int 74:664-673.
8. Heller F, et al. (2007) The contribution of B cells to renal interstitial inflammation. Am J Pathol 170:457-468. (Pubitemid 47339383)
9. Thaunat O, Patey N, Morelon E, Michel JB, Nicoletti A (2006) Lymphoid neogenesis in chronic rejection: the murderer is in the house. Curr Opin Immunol 18:576-579. (Pubitemid 44311452)
10. Segerer S, Schlondorff D (2008) B cells and tertiary lymphoid organs in renal inflammation. Kidney Int 73:533-537. (Pubitemid 351264112)
11. Thaunat O, et al. (2010) Chronic rejection triggers the development of an aggressive intragraft immune response through recapitulation of lymphoid organogenesis. J Immunol 185:717-728.
12. Carragher DM, Rangel-Moreno J, Randall TD (2008) Ectopic lymphoid tissues and local immunity. Semin Immunol 20:26-42.
13. Sarwal M, et al. (2003) Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 349:125-138. (Pubitemid 36818782)
14. Moreso F, et al. (2007) Immunephenotype of glomerular and interstitial infiltrating cells in protocol renal allograft biopsies and histological diagnosis. Am J Transplant 7:2739-2747. (Pubitemid 350045787)
15. Eckl-Dorna J, Batista FD (2009) BCR-mediated uptake of antigen linked to TLR9 ligand stimulates B-cell proliferation and antigen-specific plasma cell formation. Blood 113:3969-3977.
16. Lopatin DE, Mangan DF, Horner IS, Peebles FL (1980) Mitogen-induced amplification of blastogenesis in lipopolysaccharide-precultured lymphocytes. Infect Immun 29:512-519. (Pubitemid 10040165)
17. Sieling PA, Chung W, Duong BT, Godowski PJ, Modlin RL (2003) Toll-like receptor 2 ligands as adjuvants for human Th1 responses. J Immunol 170:194-200. (Pubitemid 36026140)
18. Marshak-Rothstein A (2006) Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 6:823-835.
19. Minguet S, et al. (2008) Enhanced B-cell activation mediated by TLR4 and BCR cross-talk. Eur J Immunol 38:2475-2487.
20. Lau CM, et al. (2005) RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J Exp Med 202:1171-1177. (Pubitemid 41586947)
21. Viglianti GA, et al. (2003) Activation of autoreactive B cells by CpG dsDNA. Immunity 19:837-847. (Pubitemid 37542304)
22. Leadbetter EA, et al. (2002) Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416:603-607. (Pubitemid 34406754)
23. Brightbill HD, et al. (1999) Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285:732-736.
24. Quintana FJ, Solomon A, Cohen IR, Nussbaum G (2008) Induction of IgG3 to LPS via Toll-like receptor 4 co-stimulation. PLoS One 3:e3509.
25. Vordermeier M, Stab K, Bessler WG (1986) A defined fragment of bacterial protein I (OmpF) is a polyclonal B-cell activator. Infect Immun 51:233-239. (Pubitemid 16200024)
26. Yao SY, Stratton CW, Mitchell WM, Sriram S (2001) CSF oligoclonal bands in MS include antibodies against Chlamydophila antigens. Neurology 56:1168-1176. (Pubitemid 32405710)
27. Wotherspoon AC, et al. (1993) Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342:575-577. (Pubitemid 23259233)
28. Wundisch T, et al. (2003) Etiology and therapy of Helicobacter pylori-associated gastric lymphomas. Ann Hematol 82:535-545. (Pubitemid 37220669)
29. Bertoni F, Zucca E (2006) Delving deeper into MALT lymphoma biology. J Clin Invest 116:22-26. (Pubitemid 43121785)
30. Zullo A, et al. (2009) Eradication therapy for Helicobacter pylori in patients with gastric MALT lymphoma: A pooled data analysis. Am J Gastroenterol 104:1932-1937 quiz 1938.
31. Lee HK, Lee J, Tobias PS (2002) Two lipoproteins extracted from Escherichia coli K-12 LCD25 lipopolysaccharide are the major components responsible for Toll-like receptor 2-mediated signaling. J Immunol 168:4012-4017. (Pubitemid 34298406)
32. Raetz CR, Reynolds CM, Trent MS, Bishop RE (2007) Lipid A modification systems in gram-negative bacteria. Annu Rev Biochem 76:295-329.
33. Raetz CR, et al. (2006) Kdo2-Lipid A of Escherichia coli, a defined endotoxin that activates macrophages via TLR-4. J Lipid Res 47:1097-1111. (Pubitemid 43764706)
34. Baba T, et al. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: The Keio collection. Mol Syst Biol 2:20060008.
35. Porat YB, Zan-Bar I, Ravid A (1995) Quantitative dot-blot assay for low titer anti-lipopolysaccharide antibodies in human plasma. J Immunol Methods 180:213-218.
36. Pollack M, Raubitschek AA, Larrick JW (1987) Human monoclonal antibodies that recognize conserved epitopes in the core-lipid A region of lipopolysaccharides. J Clin Invest 79:1421-1430. (Pubitemid 17099646)
37. Cross AS, Sidberry H, Sadoff JC (1989) The human antibody response during natural bacteremic infection with gram-negative bacilli against lipopolysaccharide core determinants. J Infect Dis 160:225-236. (Pubitemid 19189014)
38. Di Padova FE, et al. (1993) A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides. Infect Immun 61:3863-3872. (Pubitemid 23260060)
39. Brooks CL, et al. (2010) Antibodies raised against chlamydial lipopolysaccharide antigens reveal convergence in germline gene usage and differential epitope recognition. Biochemistry (Mosc) 49:570-581.
40. Saemann M, Horl WH (2008) Urinary tract infection in renal transplant recipients. Eur J Clin Invest 2(38 Suppl):58-65.
41. Mattsby-Baltzer I, et al. (1982) Experimental Escherichia coli ascending pyelonephritis in rats: Changes in bacterial properties and the immune response to surface antigens. Infect Immun 35:639-646. (Pubitemid 12164764)
42. Misselwitz J, Neubert H, Horn A, Erler W (1986) Lipid-A-antibodies- indicators for the risk of renal scarring in children with urinary tract infection. Acta Paediatr Scand 75:982-987. (Pubitemid 17185113)
43. Mattsby-Baltzer I, et al. (1981) Antibodies to lipid A during urinary tract infection. J Infect Dis 144:319-328. (Pubitemid 11017963)
44. Marrs CF, Zhang L, Foxman B (2005) Escherichia coli mediated urinary tract infections: Are there distinct uropathogenic E. coli (UPEC) pathotypes? FEMS Microbiol Lett 252:183-190. (Pubitemid 41531642)
45. Johnson JR, et al. (2010) Escherichia coli sequence type ST131 as an emerging fluoroquinolone- resistant uropathogen among renal transplant recipients. Antimicrob Agents Chemother 54:546-550.
46. Gluba A, et al. (2010) The role of Toll-like receptors in renal diseases. Nat Rev Nephrol 6:224-235.